Maven Bio Analysis: $500K Raised
What is Maven Bio?
Maven Bio offers an AI platform for BioPharma professionals to improve research efficiency and decision-making through advanced tools and workflows.
Employees
6
Founded
2023
Business Model
AI platform for BioPharma; revenue from subscriptions and consulting services.
Investors
- Y Combinator
- NVO Capital
Product Features & Capabilities
- Maven Workflows, Maven Atlas, Maven Compass, Maven Assistant, collaborative research tasks, interactive indication landscapes, natural language search for data, instant answers with primary sources.
Pricing
- Team Plan:
- 1500 Research Credits / Month
- 1500 Export Credits / Month
- Workflows
- Atlas
- Compass
- Assistant
- Database Access
- Enterprise Plan:
- Everything in Team
- Unlimited Research Credits
- 3000 Export Credits / Month
- Personalized Onboarding
- Prio
How much Maven Bio raised
Pre-Seed - $500,000
September 6, 2023Lead Investor: Y Combinator, NVO Capital
Who are the founders of Maven Bio
MB
Michael Brady
Founder
AM
Arjun Murthy
Founder
Market Focus
Maven Bio primarily focuses on the BioPharma industry, providing a domain-specific AI platform for consultants, investors, and in-house teams to enhance decision-making and reduce manual work.
Competitors Overview
Maven Bio's main competitors in the bio-pharmaceutical AI platform market include:
- Archon Bio: Ranked 1st among competitors, Archon Bio provides a computational platform for developing protein therapeutics. It has raised $20 million in funding from investors like Alexandria and Madrona Ventu
See something that needs updating? Suggest edits to this profile.